DWD 81.06(3)(e)
(e)
Electrical muscle stimulation. For purposes of this paragraph, “electrical muscle stimulation" includes galvanic stimulation, transcutaneous electrical nerve stimulation, interferential, and microcurrent techniques. All of the following guidelines apply to electrical muscle stimulation:
DWD 81.06(3)(e)1.b.
b. Maximum treatment frequency is up to 5 times per week for the first one to 3 weeks decreasing in frequency until the end of the maximum treatment duration period in
subd. 1. c.
DWD 81.06(3)(e)1.c.
c. Maximum treatment duration is 12 weeks of treatment in a clinical setting but only if given in conjunction with other therapies.
DWD 81.06(3)(e)2.
2. Home use of an electrical stimulation device may be prescribed at any time during a course of treatment. Initial use of an electrical stimulation device shall be in a supervised setting in order to ensure proper electrode placement and patient education. All of the following guidelines apply to home use of an electrical muscle stimulation device:
DWD 81.06(3)(e)2.b.
b. Patient may use the electrical stimulation device for one month, at which time effectiveness of the treatment shall be reevaluated by a health care provider before continuing home use of the device.
DWD 81.06(3)(f)
(f)
Mechanical traction. All of the following guidelines apply to mechanical traction:
DWD 81.06(3)(f)1.b.
b. Maximum treatment frequency is up to 3 times per week for the first one to 3 weeks decreasing in frequency until the end of the maximum treatment duration period in
subd. 1. c.
DWD 81.06(3)(f)1.c.
c. Maximum treatment duration is 12 weeks in a clinical setting but only if used in conjunction with other therapies.
DWD 81.06(3)(f)2.
2. Home use of a mechanical traction device may be prescribed as follow-up to use of traction in a clinical setting if it has proven to be effective treatment and is expected to continue to be effective treatment. Initial use of a mechanical traction device shall be in a supervised setting in order to ensure proper patient education. All of the following guidelines apply to home use of a mechanical traction device:
DWD 81.06(3)(f)2.b.
b. Patient may use the mechanical traction device for one month, at which time effectiveness of the treatment shall be reevaluated by a health care provider before continuing home use of the device.
DWD 81.06(3)(g)
(g)
Acupuncture treatments. For purposes of this paragraph, “acupuncture treatments" include endorphin-mediated analgesic therapy that includes classic acupuncture and acupressure. All of the following guidelines apply to acupuncture treatments:
DWD 81.06(3)(g)2.
2. Maximum treatment frequency is up to 3 times per week for one to 3 weeks decreasing in frequency until the end of the maximum treatment duration period in
subd. 3.
DWD 81.06(3)(h)
(h)
Manual therapy. For purposes of this paragraph, “manual therapy" includes soft tissue and joint mobilization, therapeutic massage, and manual traction. All of the following guidelines apply to manual therapy:
DWD 81.06(3)(h)2.
2. Maximum treatment frequency is up to 5 times per week for the first one to 2 weeks decreasing in frequency until the end of the maximum treatment duration period in
subd. 3.
DWD 81.06(3)(i)
(i)
Phoresis. For purposes of this paragraph, “phoresis" includes iontophoresis and phonophoresis. All of the following guidelines apply to phoresis:
DWD 81.06(3)(i)2.
2. Maximum treatment frequency is up to 3 times per week for the first one to 3 weeks decreasing in frequency until the end of the maximum treatment duration period in
subd. 3.
DWD 81.06(3)(i)3.
3. Maximum treatment is 9 sessions of either iontophoresis or phonophoresis, or combination, to any one site, with a maximum duration of 12 weeks for all treatment.
DWD 81.06(3)(j)
(j)
Bedrest. Prolonged restriction of activity and immobilization are detrimental to a patient's recovery. Bedrest shall not be prescribed for more than 7 days.
DWD 81.06(3)(k)
(k)
Spinal braces and other movement restricting appliances. All of the following guidelines apply to spinal braces and other movement-restricting appliances:
DWD 81.06(3)(k)1.
1. Bracing required for longer than 2 weeks shall be accompanied by active muscle strengthening exercise to avoid deconditioning and prolonged disability.
DWD 81.06(3)(k)3.
3. Treatment frequency is limited to intermittent use during times of increased physical stress or prophylactic use at work.
DWD 81.06(3)(k)4.
4. Maximum continuous duration is 3 weeks unless patient is status postfusion.
DWD 81.06(4)(a)(a) Active treatment modalities shall be used as set forth in
pars. (b) to
(f). A health care provider's use of active treatment modalities may extend past the 12-week limitation on passive treatment modalities so long as the maximum durations for the active treatment modalities are not exceeded.
DWD 81.06(4)(b)
(b) Education shall teach the patient about pertinent anatomy and physiology as it relates to spinal function for the purpose of injury prevention. Education includes training on posture, biomechanics, and relaxation. The maximum number of treatments is 3 visits, which include an initial education and training session and 2 follow-up visits.
DWD 81.06(4)(c)
(c) Posture and work method training shall instruct the patient in the proper performance of job activities. Topics include proper positioning of the trunk, neck and arms, use of optimum biomechanics in performing job tasks, and appropriate pacing of activities. Methods include didactic sessions, demonstrations, exercises, and simulated work tasks. The maximum number of treatments is 3 visits.
DWD 81.06(4)(d)
(d) Worksite analysis and modification shall examine the patient's work station, tools, and job duties. A health care provider's recommendations may be made for the alteration of the work station, selection of alternate tools, modification of job duties, and provision of adaptive equipment. The maximum number of treatments is 3 visits.
DWD 81.06(4)(e)
(e) Exercise, which is important to the success of an initial nonsurgical treatment program and a return to normal activity, shall include active patient participation in activities designed to increase flexibility, strength, endurance, or muscle relaxation. Exercise shall, at least in part, be specifically aimed at the musculature of the lumbosacral spine. Aerobic exercise and extremity strengthening may be performed as adjunctive treatment, but may not be the primary focus of the exercise program.
DWD 81.06(4)(f)
(f) Exercises shall be evaluated to determine if the desired goals are being attained. Strength, flexibility, and endurance shall be objectively measured. A health care provider may objectively measure the treatment response as often as necessary for optimal care after the initial evaluation.
Subdivisions 1. and
2. govern supervised and unsupervised exercise, except for computerized exercise programs and health clubs, which are governed by
s. DWD 81.13.
DWD 81.06(4)(f)1.
1. `Guidelines for supervised exercise.' One goal of an exercise program shall be to teach the patient how to maintain and maximize any gains experienced from exercise. Self-management of the condition shall be promoted. All of the following guidelines apply to supervised exercise:
DWD 81.06(4)(f)1.a.
a. Maximum treatment frequency is 5 times for the first week decreasing to 3 times per week for the next 2 weeks and decreasing in frequency after the third week.
DWD 81.06(4)(f)2.
2. `Guidelines for unsupervised exercise.' Unsupervised exercise shall be provided in the least intensive setting appropriate to the goals of the exercise program and may supplement or follow the period of supervised exercise. All of the following guidelines apply to unsupervised exercise:
DWD 81.06(4)(f)2.a.
a. Maximum treatment frequency is up to 3 visits for instruction and monitoring.
DWD 81.06(5)(a)(a) Injection modalities are necessary as set forth in
pars. (b) to
(d). A health care provider's use of injections may extend past the 12-week limit on passive treatment modalities so long as the maximum treatment for injections is not exceeded.
DWD 81.06(5)(b)
(b) For purposes of this subsection, “therapeutic injections" include injections of trigger points, facet joints, facet nerves, sacroiliac joints, sympathetic nerves, epidurals, nerve roots, and peripheral nerves. Therapeutic injections may only be given in conjunction with active treatment modalities directed to the same anatomical site.
DWD 81.06(5)(b)1.
1. All of the following guidelines apply to trigger point injections:
DWD 81.06(5)(b)1.b.
b. Maximum treatment frequency is once per week to any one site if there is a positive response to the first injection at that site. If subsequent injections at that site demonstrate diminishing control of symptoms or fail to facilitate objective functional gains, then trigger point injections shall be redirected to other areas or discontinued. No more than 3 injections to different sites per patient visit may be given.
DWD 81.06(5)(b)2.
2. All of the following guidelines apply to sacroiliac joint injections:
DWD 81.06(5)(b)2.b.
b. Maximum treatment frequency may permit repeat injection 2 weeks after the previous injection if there is a positive response to the first injection. Only 2 injections per patient visit.
DWD 81.06(5)(b)3.
3. All of the following guidelines apply to facet joint or nerve injections:
DWD 81.06(5)(b)3.b.
b. Maximum treatment frequency is once every 2 weeks to any one site if there is a positive response to the first injection. If subsequent injections demonstrate diminishing control of symptoms or fail to facilitate objective functional gains, then injections shall be discontinued. Only 3 injections to different sites per patient visit.
DWD 81.06(5)(b)4.b.
b. Maximum treatment frequency may permit repeat injection 2 weeks after the previous injection if there is a positive response to the first injection. Only 3 injections to different sites per patient visit.
DWD 81.06(5)(b)4.c.
c. Maximum treatment is 2 injections to any one site. Maximum treatment is 2 injections to any one site.
DWD 81.06(5)(b)5.b.
b. Maximum treatment frequency is once every 2 weeks if there is a positive response to the first injection. If subsequent injections demonstrate diminishing control of symptoms or fail to facilitate objective functional gains, then injections should be discontinued. Only one injection per patient visit.
DWD 81.06(5)(c)
(c) For purposes of this paragraph, “lytic or sclerosing injections" include radio frequency denervation of the facet joints. These injections may only be given in conjunction with active treatment modalities directed to the same anatomical site. All of the following guidelines apply to lytic or sclerosing injections:
DWD 81.06(5)(c)2.
2. Maximum treatment frequency may repeat 4 times per year or once every 3 months for any site.
DWD 81.06(5)(d)
(d) Prolotherapy and botulinum toxin injections are not necessary in the treatment of low back problems.
DWD 81.06(6)
(6) Surgery, including decompression procedures and arthrodesis. DWD 81.06(6)(b)
(b) In order to optimize the beneficial effect of surgery, postoperative therapy with active and passive treatment modalities may be provided, even if these modalities had been used in the preoperative treatment of the condition. In the postoperative period, the maximum treatment duration with passive treatment modalities in a clinical setting from the initiation of the first passive modality used, except bedrest or bracing, is as follows:
DWD 81.06(6)(b)1.
1. Eight weeks following lumbar decompression or implantation of a spinal cord stimulator or intrathecal drug delivery system.
DWD 81.06(6)(d)
(d) The surgical therapies in
subds. 1. and
2. have very limited application and require a personality or psychosocial evaluation that indicates the patient is likely to benefit from the treatment:
DWD 81.06(6)(d)1.
1. Spinal cord stimulator may be necessary for a patient who has neuropathic pain and has had a favorable response to a trial screening period.
DWD 81.06(6)(d)2.
2. Intrathecal drug delivery system may be necessary for a patient who has somatic or neuropathic pain and has had a favorable response to a trial screening period.
DWD 81.06(7)
(7) Chronic management. Chronic management of low back pain shall be provided according to the guidelines of
s. DWD 81.13.
DWD 81.06(8)(a)(a) A health care provider may direct the use of durable medical equipment in any of the following:
DWD 81.06(8)(a)2.
2. For patients using electrical muscle stimulation or mechanical traction devices at home, the device and any required supplies are necessary within the guidelines of
sub. (3) (e) and
(f).
